Long‐standing remission after 25‐OH D3 treatment in a case of chronic myelomonocytic leukaemia

Leonardo Mellibovsky, Adolfo Díez, Jaume Aubia, Xavier Nogues, Encarna Pérez‐Vila, Sergi Serrano, Robert R. Recker

Research output: Contribution to journalArticle

11 Scopus citations

Abstract

This report describes a case of chronic myelomonocytic leukaemia (CMML) in whom a complete remission was achieved and sustained 15 months after treatment with 25-OH vitamin D3. No side-effects were observed. Although vitamin D3 has been used in the treatment of myelodysplastic syndromes, to our knowledge this is the first case of longstanding remission in a patient with CMML. This 'differentiation therapy' might be considered as a possible alternative in the management of this disease.

Original languageEnglish (US)
Pages (from-to)811-812
Number of pages2
JournalBritish Journal of Haematology
Volume85
Issue number4
DOIs
StatePublished - Dec 1993

All Science Journal Classification (ASJC) codes

  • Hematology

Fingerprint Dive into the research topics of 'Long‐standing remission after 25‐OH D3 treatment in a case of chronic myelomonocytic leukaemia'. Together they form a unique fingerprint.

  • Cite this